tradingkey.logo

AbbVie rises on profit forecast lift, upbeat quarter

ReutersApr 25, 2025 11:51 AM

Shares of drugmaker AbbVie ABBV.N rise 2.7% to $185.3 premarket

AbbVie raises its 2025 profit forecast after better-than-expected sales of its newer immunology drugs Skyrizi and Rinvoq help it beat quarterly earnings expectations

Company expects its annual adjusted profit to be between $12.09 and $12.29 per share, up from its previous estimate of $11.99 to $12.19

ABBV earns adj. Q1 profit of $2.46 per share, compared with analysts' average expectation of $2.38

As of last close, ABBV had risen 1.5% YTD

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI